<html>
<head>PUBMED IDs for CML66</head>
<body bgcolor='#C5F0F2'><h1>CML66</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11416219/'>CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.</a> June 21  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/14688378/'>A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L.</a> December 23  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/18534745/'>RNA interference targeting CML66, a novel tumor antigen, inhibits proliferation, invasion and metastasis of HeLa cells.</a> June 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18534733/'>A letter response to Chaufan's &quot;how much can a large population study on genes, environments, their interactions and common diseases contribute to the health of the American people?&quot; (65:8, 2007, 1730-1741).</a> June 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19915374/'>[Induction and functional analysis of cytotoxic T lymphocytes specific for the novel tumor-associated antigen CML66].</a> January 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21530541/'>Structural features and chaperone activity of the NudC protein family.</a> August 2  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/26965524/'>Emerging roles of NudC family: from molecular regulation to clinical implications.</a> March 8  2016<br></body></html>
